【レポートの概要(一部)】
PART 01: Executive summary
Highlights
PART 02: Scope of the report
Market overview
Top vendor offerings
PART 03: Market research methodology
Research methodology
Economic indicators
PART 04: Introduction
Key market highlights
PART 05: Cephalosporin overview
Introduction
Precursors of cephalosporins
Mechanism of action
General principles for use of antibiotics
Clinical uses
Epidemiology
PART 06: Overview on the consumption of antibiotics
Latin America
Europe
APAC
PART 07: Legislation relating to antibiotic use in the US
PART 08: Market landscape
Market overview
Market size and forecast
Five forces analysis
PART 09: Market segmentation by generation of cephalosporin
First-generation cephalosporins
Second-generation cephalosporins
Third-generation cephalosporins
Fourth-generation cephalosporins
Fifth-generation cephalosporins
PART 10: Market segmentation by route of administration
Injection
Oral
PART 11: Geographical segmentation
Segmentation of global cephalosporin drugs market by geography
Cephalosporin drugs market in Americas
Cephalosporin drugs market in EMEA
Cephalosporin drugs market in APAC
PART 12: Market drivers
Special regulatory designation for pipeline molecules
Rise in prevalence of infectious diseases
Increase in awareness
PART 13: Impact of drivers
PART 14: Market challenges
Development of drug resistance
High generic penetration
Weak pipeline
PART 15: Impact of drivers and challenges
PART 16: Market trends
Use of combination therapies
Increase in M&A
Increasing irrational use of cephalosporins
PART 17: Vendor landscape
Competitive scenario
Market share analysis 2014
Other prominent vendors
PART 18: Key vendor analysis
Allergan
Astellas
Bristol-Myers Squibb
GSK
Merck
Pfizer
Sandoz
Teva Pharmaceuticals
PART 19: Appendix
List of abbreviations
PART 20: Explore Technavio
[List of Exhibits]
Exhibit 01: Product offerings
Exhibit 02: Evolution of cephalosporin drugs
Exhibit 03: Overview of the activity of different generations of cephalosporin drugs
Exhibit 04: General principles involved in use of antibiotics
Exhibit 05: Estimated number of cases for nosocomial infections in the US 2011
Exhibit 06: Number of cases of E.coli in the UK 2012-2014
Exhibit 07: Legislation relating to the use of antibiotics in the US
Exhibit 08: Global cephalosporin drugs market 2014-2019 ($ millions)
Exhibit 09: Five forces analysis
Exhibit 10: Global cephalosporin drugs market segment by generation
Exhibit 11: Overview of activity of different generations of cephalosporins
Exhibit 12: Evolution of different generations of cephalosporin drugs
Exhibit 13: Global cephalosporin drugs market segment by route of administration
Exhibit 14: Different generations of cephalosporin drugs by route of administration
Exhibit 15: Global cephalosporin drugs market segment by geography 2014
Exhibit 16: Global cephalosporin drugs market revenue by geography 2014-2019 ($ millions)
Exhibit 17: Cephalosporin drugs market in Americas 2014-2019 ($ millions)
Exhibit 18: Percentage share of cephalosporin market in Americas
Exhibit 19: Percentage share of market by generation of cephalosporin in the US based on revenue 2014
Exhibit 20: Cephalosporin drugs market in EMEA 2014-2019 ($ millions)
Exhibit 21: Percentage share of cephalosporin drugs market in EMEA
Exhibit 22: Percentage share of market by generation of cephalosporin in EU based on revenue 2014
Exhibit 23: Cephalosporin drugs market in APAC 2014-2019 ($ millions)
Exhibit 24: Impact of drivers
Exhibit 25: Cephalosporin resistant strains according to the period of development of resistance
Exhibit 26: Impact of drivers and challenges
Exhibit 27: Allergan: YoY growth and revenue generated from net product sales of anti-infective drugs 2011-2013 ($ millions)
Exhibit 28: Allergan: Key takeaways
Exhibit 29: Astellas: Key takeaways
Exhibit 30: Bristol-Myers Squibb: Key takeaways
Exhibit 31: GSK: Key takeaways
Exhibit 32: Merck: Key takeaways
Exhibit 33: Pfizer: Key takeaways
Exhibit 34: Sandoz: Key takeaways
Exhibit 35: Teva Pharmaceuticals: Key takeaways
Exhibit 36: Allergan: Business segmentation by product revenue 2014
Exhibit 37: Allergan: Business segmentation by revenue 2013 and 2014 ($ billions)
Exhibit 38: Allergan: Geographical segmentation by revenue 2014
Exhibit 39: Astellas: Product segmentation by revenue 2015
Exhibit 40: Astellas: Product segmentation by revenue 2014 and 2015 ($ billions)
Exhibit 41: Astellas: Geographical segmentation by revenue 2015
Exhibit 42: Bristol-Myers Squibb: Segmentation by revenue 2014
Exhibit 43: Bristol-Myers Squibb: Segmentation by revenue 2013 and 2014 ($ billions)
Exhibit 44: Bristol-Myers Squibb: Geographical segmentation by revenue 2014
Exhibit 45: GSK: Business segmentation by revenue 2014
Exhibit 46: GSK: Business segmentation by revenue 2013 and 2014 ($ billions)
Exhibit 47: GSK: Geographical segmentation by revenue 2014
Exhibit 48: Merck: Business segmentation by revenue 2014
Exhibit 49: Merck: Business segmentation by revenue 2013 and 2014 ($ billions)
Exhibit 50: Merck: Geographical segmentation by revenue 2014
Exhibit 51: Pfizer: Business segmentation by revenue 2014
Exhibit 52: Pfizer business segmentation by revenue 2013 and 2014 ($ billions)
Exhibit 53: Pfizer: Geographical segmentation by revenue 2014
Exhibit 54: Sandoz: Business segmentation by revenue 2014
Exhibit 55: Teva Pharmaceuticals: Business segmentation by revenue 2014
Exhibit 56: Teva Pharmaceuticals: Business segmentation by revenue 2013 and 2014
Exhibit 57: Teva Pharmaceuticals: Geographical segmentation by revenue 2014
【レポート販売概要】
■ タイトル:セファロスポリン系薬の世界市場2015-2019■ 英文:Global Cephalosporin Drugs Market 2015-2019
■ 発行日:2015年9月23日
■ 調査会社:Technavio
■ 商品コード:IRTNTR7550
■ 調査対象地域:グローバル
- 世界のスープ市場のM&A動向(2014年7月)Synopsis The report provides a review of the mergers and acquisitions (M&As), partnering deals, and agreements entered into by companies active in the global soups market during July 2014. Summary Using this report, dealmakers will effectively gain an insight into deal activity of the global soups market throughout the month. Additionally, the report provides an overview of all the partnering, all …
- 皮革製品の世界市場:フットウェア、バック、財布、かばんTechnavio's market research analyst predicts the leather goods industry to grow at a CAGR of around 4% during the forecast period. The rise in export of leather is the primary driver for the growth of this market. For instance, during 2014, the US exported hides, skins and semi-processed leather which generated a revenue of around USD 3 billion. China, Taiwan, Korea, Mexico, and the European count …
- 電気機関車エンジンの世界市場2017-2021ABSTRACTAbout Electric Locomotive Engines Increasing number of passengers and freight volumes drive the electric locomotive engines market in various regions. Rising concerns regarding pollution and declining air quality have pushed government bodies and private stakeholders to upgrade from diesel-electric locomotives to energy-efficient and non-polluting electric locomotives. In terms of speed an …
- メディカルテキスタイルの世界市場2015-2019About Medical Textiles Material Medical textiles is a sub-segment of the technical textiles segment, and it is one of the fastest growing sub-segments. The pertinent need for sanitation propels the demand for medical textiles. Medical textiles materials range from scaffolds for tissue culturing, simple gauze, bandage materials, to prostheses for permanent body implants. Hospitals and medical facil …
- 非横紋筋肉腫(Non-Rhabdomyosarcoma):グローバル臨床試験レビュー(2014年上半期)Non-Rhabdomyosarcoma Global Clinical Trials Review, H1, 2014 Summary GlobalData's clinical trial report, “Non-Rhabdomyosarcoma Global Clinical Trials Review, H1, 2014" provides data on the Non-Rhabdomyosarcoma clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Non-Rhabdomyosarcoma. It includes an overview of the trial numbers and their r …
- 心血管装置の世界市場分析:製品別(診断モニタリング:ECG、ホルターモニター、イベントモニター、診断カテーテル、埋め込み型ループレコーダー、心エコー検査、PETスキャン、MRI、心臓CT、心筋灌流スキャン、ドップラー胎児モニター;外科手術:ペースメーカー、ステント、カテーテル・アクセサリー、ガイドワイヤー、カニューレ、電気外科処置、バルブ、閉塞器具)、セグメント予測Global cardiovascular devices market is anticipated to reach USD 121 billion by 2024, according to a new report by Grand View Research, Inc. Increasing geriatric population, sedentary life style coupled with unhealthy dietary habits is spurring the prevalence of cardiovascular diseases. Constant rise in the patients suffering from cardiovascular diseases and is expected to drive market growth duri …
- ソフトウェア定義セキュリティ(SDS)の世界市場予測(~2021年):ソリューション、サービスThe Software-Defined Security market size is expected to grow from USD 1.59 Billion in 2016 to USD 6.76 Billion by 2021, at an estimated Compound Annual Growth Rate (CAGR) of 33.6%. Major growth drivers of the SDSec market are need for policy-driven, scalable, and programmable security architecture; faster response against threats/risks and requirement for increased security; security staffing and …
- 小売向けディスプレイの世界市場2016-2020About Retail Display Displays are used to exhibit data or information. They are referred to as retail displays when used in retail applications like POS systems, kiosks, ATMs, and digital signage. They can be both touch-enabled and non-touch displays. A growing number of retailers are using interactive displays to attract customers. Retailers have to make sure that their digital displays are techn …
- December Monthly Deals Roundup:防衛産業Why was the report written? Using this report, dealmakers will effectively gain an insight into deal activity during the month. Additionally, the report provides an overview of all the partnering, alliances, and M&A deals announced worldwide. What makes this report unique and essential to read? The Monthly Report provides the reader with the top-line data necessary to quickly keep abreast of deal …
- 医療用高分子の世界市場2017-2021:繊維・樹脂、医療用エラストマー、生分解性医療用高分子About Medical Polymers Polymers are composed of many repeated subunits of monomer. Polymers find a wide range of applications in the medical industry, including implants, diagnostic systems, and accessories. Medical polymers are lighter in weight as compared with other counterparts such as metals and thus, are preferred for lightweight applications. In addition, biodegradable polymers also elimina …
- 高機能フィルム(HPF)の世界市場:ポリエステル、EVA、ポリオレフィン、ポリアミド、ポリカーボネート、ふっ素ポリマThe global high-performance film (HPF) market, in terms of value, is projected to reach USD 42.25 Billion by 2020, growing at a CAGR of 7.51% from 2015 to 2020. High-growth application areas such as construction, packaging, automotive & transportation, and electrical & electronics, and extensive product launch and agreement & collaboration activities by companies are key factors driving the growth …
- ボツリヌス症(Botulism)の治療薬パイプライン動向(2015年上半期版)Botulism - Pipeline Review, H1 2015 Summary Global Markets Direct’s, ‘Botulism - Pipeline Review, H1 2015’, provides an overview of the Botulism’s therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Botulism, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administr …
- Acciona Energia, S.A.:発電所及びSWOT分析2013Acciona Energia, S.A. - Power Plants and SWOT Analysis, 2013 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on key employees (executives), and major products and services. Scope - Major Power Plants (assets) - summarized a …
- 産業用ローラーチェーンドライブの世界市場About Industrial Roller Chain DrivesAn industrial roller chain drive is a type of chain drive that is commonly applied for transmission of machine-driven power from industrial and agricultural machinery. It is used in machinery to drive with the help of a sprocket. These industrial roller chains are commonly used in low-speed to mid-speed drives, and a few high-speed drive applications. Technavio’ …
- 世界の脊椎インプラント(医療デバイス)市場:融合/非融合インプラントAbout Spinal Implants Spinal implants are devices that help preserve and restore the functions of the spine by managing spinal disorders. Spinal disorders can be degenerative, deformities, trauma, and tumors. Some of the spinal disorders are spondylolisthesis, scoliosis, disc herniation, and spinal stenosis. Spinal implants are composed of metals such as titanium, titanium-alloy, and stainless ste …